Study List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Report Bug
Study List
You are on Page 764 of 776:
754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00055120 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED When to Start Anti-HIV Drugs in Patients With Opportunistic Infections PHASE4 View
NCT00055094 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Treatment of Acute HIV Infection to Preserve Immune Function View
NCT00055068 Rhode Island Hospital COMPLETED Family Based Treatment of Early Childhood Obsessive Compulsive Disorder PHASE3 View
NCT00055016 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Registry of Fabry Disease - A Multicenter Observational Study View
NCT00055003 National Institute of Mental Health (NIMH) COMPLETED Effect of Hydrocortisone on the Brain View
NCT00054951 FeRx UNKNOWN Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads PHASE1 View
NCT00054912 Epimmune COMPLETED An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer PHASE1 View
NCT00054860 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults PHASE1 View
NCT00054834 Gilead Sciences TERMINATED Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma PHASE1 View
NCT00054795 Positive Gene Therapy Pharmacyclics LLC. COMPLETED Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) PHASE3 View
NCT00054769 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Diagnosing Tuberculosis in HIV Infected Children in Peru View
NCT00054756 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities PHASE2 View
NCT00054704 National Institute of Mental Health (NIMH) TERMINATED Riluzole to Treat Depression in Bipolar Disorder PHASE2 View
NCT00054561 Positive Gene Therapy Eastern Cooperative Oncology Group COMPLETED Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer PHASE3 View
NCT00054535 National Cancer Institute (NCI) COMPLETED Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE2 View
NCT00054457 Alliance for Clinical Trials in Oncology COMPLETED Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction PHASE2 View
NCT00054418 Alliance for Clinical Trials in Oncology COMPLETED Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer PHASE3 View
NCT00054405 National Cancer Institute (NCI) TERMINATED Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma PHASE1 View
NCT00054392 Fox Chase Cancer Center WITHDRAWN Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer PHASE3 View
NCT00054158 Roswell Park Cancer Institute COMPLETED Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma PHASE2 View
NCT00054132 National Cancer Institute (NCI) COMPLETED Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer PHASE2 View
NCT00054067 Gynecologic Oncology Group TERMINATED Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix PHASE3 View
NCT00054002 Roswell Park Cancer Institute COMPLETED Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma PHASE2 View
NCT00053950 National Cancer Institute (NCI) TERMINATED Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma PHASE1 View
NCT00053833 SWOG Cancer Research Network TERMINATED S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer PHASE2 View
NCT00053820 Medical Research Council COMPLETED Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer PHASE3 View
NCT00053794 NCIC Clinical Trials Group COMPLETED Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma PHASE2 View
NCT00053768 German High-Grade Non-Hodgkin's Lymphoma Study Group COMPLETED Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma PHASE3 View
NCT00053703 University of North Carolina, Chapel Hill COMPLETED Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) PHASE4 View
NCT00053651 Butler Hospital COMPLETED Prevention of Postpartum Depression in Low-Income Women PHASE1 View
NCT00053560 Genelabs Technologies UNKNOWN To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids PHASE3 View
NCT00053534 Mayo Clinic COMPLETED Heart Failure in the Community View
NCT00053495 Emergent BioSolutions COMPLETED Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination PHASE2 View
NCT00053469 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) COMPLETED Infant s Examination and Manipulation of Objects View
NCT00053456 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED The Effect of Exercise on Stem Cell Mobilization and Heart Function in Patients Undergoing Cardiac Rehabilitation View
NCT00053404 National Institute of Allergy and Infectious Diseases (NIAID) UNKNOWN Immunologic Control of Drug Resistant HIV View
NCT00053300 Case Comprehensive Cancer Center COMPLETED Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer PHASE2 View
NCT00053261 Gynecologic Oncology Group COMPLETED Vaginal Changes and Sexual Function in Patients With Cervical Cancer View
NCT00053235 Gynecologic Oncology Group WITHDRAWN Research Study in Patients With Advanced Ovarian Epithelial Cancer View
NCT00053157 Roswell Park Cancer Institute COMPLETED Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia NA View
NCT00053118 Roswell Park Cancer Institute COMPLETED Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer PHASE1 View
NCT00053105 Theradex UNKNOWN Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma PHASE1 View
NCT00053092 Institute of Cancer Research, United Kingdom COMPLETED Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma PHASE2 View
NCT00052832 Positive Gene Therapy University of Wisconsin, Madison COMPLETED Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia PHASE2 View
NCT00052559 National Cancer Institute (NCI) COMPLETED Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer PHASE1 View
NCT00052520 Fred Hutchinson Cancer Center COMPLETED Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation PHASE1 View
NCT00052494 University Health Network, Toronto COMPLETED Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer PHASE1 View
NCT00052468 AGO Study Group COMPLETED Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer PHASE3 View
NCT00052403 Barbara Ann Karmanos Cancer Institute WITHDRAWN Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00052351 National Cancer Institute (NCI) COMPLETED Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer PHASE2 View
NCT00052195 Dartmouth-Hitchcock Medical Center COMPLETED Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People PHASE2 View
NCT00052169 NSABP Foundation Inc COMPLETED Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer PHASE2 View
NCT00052156 CancerVax Corporation UNKNOWN Vaccine Therapy for Patients With Stage IV Melanoma PHASE3 View
NCT00052104 Rhode Island Hospital COMPLETED Telephone-Based Support for Caregivers of Patients With Dementia PHASE2 View
NCT00051961 Positive Gene Therapy National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome View
NCT00051935 Genzyme, a Sanofi Company COMPLETED A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II PHASE2 View
NCT00051857 National Institutes of Health Clinical Center (CC) RECRUITING MRI Study of Musculoskeletal Function View
NCT00051818 The Wistar Institute COMPLETED Immune and Viral Outcomes of HIV-1 Therapy Interruption PHASE1 View
NCT00051805 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Promoting Adherence to Anti-HIV Drug Regimens NA View
NCT00051792 Positive Gene Therapy National Center for Complementary and Integrative Health (NCCIH) COMPLETED Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) PHASE1 View
NCT00051766 National Institute of Allergy and Infectious Diseases (NIAID) TERMINATED Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs NA View
NCT00051558 Eli Lilly and Company COMPLETED Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis PHASE3 View
NCT00051532 LEO Pharma TERMINATED Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma NA View
NCT00051493 Eli Lilly and Company COMPLETED ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. PHASE2 View
NCT00051467 GenVec COMPLETED A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer PHASE3 View
NCT00051428 National Center for Complementary and Integrative Health (NCCIH) COMPLETED The Efficacy of Reiki in the Treatment of Fibromyalgia PHASE1 View
NCT00051402 National Center for Complementary and Integrative Health (NCCIH) COMPLETED Phytoestrogens and Memory Decline in Menopause PHASE2 View
NCT00051350 Johns Hopkins University COMPLETED OmniHeart Trial: Macronutrients and Cardiovascular Risk NA View
NCT00051259 GlaxoSmithKline COMPLETED Effects of Antidepressants on Sexual Functioning PHASE3 View
NCT00051233 Positive Gene Therapy University of Pittsburgh COMPLETED Treatment of Schizophrenia Through Internet-Based Psychoeducation PHASE2 View
NCT00051220 Virginia Polytechnic Institute and State University COMPLETED Treatment for Specific Phobias in Children PHASE1 View
NCT00051194 Alcon Research COMPLETED A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension PHASE2 View
NCT00051168 Alcon Research COMPLETED A Long-term Safety Study of Once-daily Travatan PHASE3 View
NCT00051103 GlaxoSmithKline COMPLETED Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. PHASE2 View
NCT00051051 Pfizer COMPLETED A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer PHASE2 View
NCT00051012 Eisai Inc. COMPLETED Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients PHASE4 View
NCT00050960 Eisai Inc. COMPLETED Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer PHASE3 View
NCT00050934 Positive Gene Therapy Novartis Pharmaceuticals COMPLETED Pediatric Epilepsy Study PHASE3 View
NCT00050895 Positive Gene Therapy National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients PHASE3 View
NCT00050869 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Learning a Motor Task Through Observation View
NCT00050856 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection PHASE3 View
NCT00050804 National Institute of Mental Health (NIMH) COMPLETED Evaluation of Stress Disorders PHASE4 View
NCT00050661 Rockefeller University COMPLETED To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris PHASE1 View
NCT00050635 Novartis Pharmaceuticals COMPLETED STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea PHASE4 View
NCT00050557 Mary Fristad COMPLETED Family Psychoeducation for Children With Mood Disorders PHASE1 View
NCT00050518 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED APSV in Vaccinia Naive Adults PHASE2 View
NCT00050505 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Expanded Dryvax Dilution Study in Previously Vaccinated Adults PHASE2 View
NCT00050492 National Eye Institute (NEI) COMPLETED Biological Markers in Retinal Vasculitis View
NCT00050466 National Eye Institute (NEI) COMPLETED Dynamic Light Scattering and Keratoscopy for Corneal Examination View
NCT00050232 Avanir Pharmaceuticals COMPLETED Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients PHASE3 View
NCT00050193 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Cause and Natural Course of Pediatric-Onset Mastocytosis View
NCT00050167 M.D. Anderson Cancer Center COMPLETED Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer PHASE1 View
NCT00050102 Bristol-Myers Squibb COMPLETED Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma PHASE2 View
NCT00050050 Massachusetts General Hospital COMPLETED Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder PHASE1 View
NCT00049959 QLT Inc. TERMINATED Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. PHASE3 View
NCT00049933 University of Washington COMPLETED Hormone Replacement Therapy and Prothrombotic Variants View
NCT00049920 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED The ARIC MRI Study View
NCT00049894 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Predictors of Recurrent Stroke in the PROGRESS Study View
NCT00049868 Rutgers University COMPLETED Enhanced Linkage Maps From Family-Based Genetics Studies View
NCT00049803 Orphan Medical COMPLETED Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients PHASE3 View
NCT00049751 Abbott COMPLETED Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis PHASE3 View
NCT00049660 European Organisation for Research and Treatment of Cancer - EORTC TERMINATED Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer PHASE2 View
NCT00049634 Fred Hutchinson Cancer Center COMPLETED Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder PHASE1 View
NCT00049595 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma PHASE3 View
NCT00049569 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia NA View
NCT00049556 National Cancer Institute (NCI) COMPLETED Gefitinib in Treating Patients With Cervical Cancer PHASE2 View
NCT00049504 Fred Hutchinson Cancer Center COMPLETED Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer PHASE2 View
NCT00049361 Wake Forest University Health Sciences COMPLETED Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases PHASE2 View
NCT00049335 SWOG Cancer Research Network COMPLETED S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed PHASE2 View
NCT00049257 Jonsson Comprehensive Cancer Center COMPLETED Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy PHASE2 View
NCT00049218 H. Lee Moffitt Cancer Center and Research Institute COMPLETED Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer PHASE1 View
NCT00049192 National Cancer Institute (NCI) COMPLETED Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia PHASE2 View
NCT00049166 National Cancer Institute (NCI) COMPLETED Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer PHASE1 View
NCT00049127 Alliance for Clinical Trials in Oncology COMPLETED Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor PHASE1 View
NCT00048958 Alliance for Clinical Trials in Oncology ACTIVE_NOT_RECRUITING Cytogenetic Studies in Acute Leukemia and Multiple Myeloma View
NCT00048932 Bristol-Myers Squibb COMPLETED A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis PHASE3 View
NCT00048906 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Alpha-Galactosidase A Replacement Therapy for Fabry Disease PHASE2 View
NCT00048893 National Cancer Institute (NCI) TERMINATED Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer PHASE1 View
NCT00048802 Positive Gene Therapy Northwell Health COMPLETED Treatment and Outcome of Early Onset Bipolar Disorder PHASE4 View
NCT00048750 Astellas Pharma Inc TERMINATED Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU PHASE3 View
NCT00048659 Astellas Pharma Inc TERMINATED YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy PHASE2 View
NCT00048633 Positive Gene Therapy QLT Inc. COMPLETED Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer PHASE2 View
NCT00048620 BioMarin Pharmaceutical COMPLETED Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI PHASE1 View
NCT00048594 Merck Sharp & Dohme LLC COMPLETED Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED) PHASE3 View
NCT00048568 Bristol-Myers Squibb COMPLETED A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate PHASE3 View
NCT00048503 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older PHASE2 View
NCT00048451 Abbott COMPLETED Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) PHASE3 View
NCT00048412 Baylor College of Medicine COMPLETED Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H PHASE1 View
NCT00048360 GlaxoSmithKline COMPLETED Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults PHASE3 View
NCT00048334 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Depsipeptide to Treat Thyroid and Other Advanced Cancers PHASE1 View
NCT00048295 Ionis Pharmaceuticals, Inc. COMPLETED Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease PHASE3 View
NCT00048256 National Institutes of Health Clinical Center (CC) COMPLETED Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates View
NCT00048204 GlaxoSmithKline COMPLETED A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder PHASE2 View
NCT00048061 Hoffmann-La Roche COMPLETED MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis PHASE3 View
NCT00048035 Hoffmann-La Roche COMPLETED A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia PHASE2 View
NCT00047957 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Brain Inhibition of Muscle Movement in Normal Volunteers View
NCT00047918 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing View
NCT00047905 National Human Genome Research Institute (NHGRI) COMPLETED Pilot Study of the Process of Prenatal Genetic Counseling NA View
NCT00047866 National Institute on Alcohol Abuse and Alcoholism (NIAAA) COMPLETED Brain Function in Response to Motivational Stimuli View
NCT00047658 InterMune COMPLETED A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) PHASE2 View
NCT00047632 InterMune TERMINATED Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer PHASE3 View
NCT00047593 Alcon Research COMPLETED Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 PHASE3 View
NCT00047567 Elan Pharmaceuticals TERMINATED Open-label Adjunctive Zonisamide for Bipolar Disorder PHASE4 View
NCT00047528 Positive Gene Therapy Alcon Research COMPLETED Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 PHASE3 View
NCT00047502 M.D. Anderson Cancer Center COMPLETED Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia PHASE1 View
NCT00047450 Veterans Medical Research Foundation COMPLETED Antidepressant Treatment in Older Adults With Schizophrenia NA View
NCT00047333 National Cancer Institute (NCI) TERMINATED Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed PHASE2 View
NCT00047320 Children's Oncology Group COMPLETED Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors PHASE2 View
NCT00047294 Dana-Farber Cancer Institute COMPLETED Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme PHASE2 View
NCT00047268 European Working Group of MDS in Childhood UNKNOWN Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome PHASE3 View
NCT00047203 National Cancer Institute (NCI) COMPLETED Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE2 View
NCT00047060 Positive Gene Therapy National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome PHASE1 View
NCT00047034 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED E7389 in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00046995 Groupe Regional d'Etudes du Cancer Colorectal UNKNOWN Combination Chemotherapy in Treating Patients With Colon Cancer PHASE3 View
NCT00046969 AGO Study Group COMPLETED Epoetin Beta in Treating Anemia in Patients With Cervical Cancer PHASE4 View
NCT00046904 Mayo Clinic COMPLETED Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer PHASE3 View
NCT00046761 Positive Gene Therapy Ono Pharma USA Inc TERMINATED A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke PHASE2 View
NCT00046735 Celgene COMPLETED Phase 1 Study OF CDC-501 in Patients With Solid Tumors PHASE1 View
NCT00046657 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Longitudinal Study of Neighborhood Predictors of CVD View
NCT00046618 Mayo Clinic COMPLETED Mapping Novel Disease Genes for Dilated Cardiomyopathy View
NCT00046605 University of Washington COMPLETED Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA View
NCT00046592 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Mechanisms of Disability in Peripheral Arterial Disease View
NCT00046566 Positive Gene Therapy Tulane University COMPLETED Clinical Trial of Dietary Protein and Blood Pressure NA View
NCT00046358 National Institute of Mental Health (NIMH) COMPLETED The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease PHASE4 View
NCT00046332 GlaxoSmithKline COMPLETED A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients PHASE2 View
NCT00046293 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED ReoPro and Retavase to Treat Acute Stroke PHASE2 View
NCT00046267 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients NA View
NCT00046202 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) COMPLETED Study of Inborn Errors of Cholesterol Synthesis and Related Disorders View
NCT00046150 Sanofi COMPLETED 12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. PHASE3 View
NCT00046059 National Human Genome Research Institute (NHGRI) COMPLETED Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) View
NCT00046033 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance PHASE2 View
NCT00046020 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Evaluating Venlafaxine ER in Recurrent Depression PHASE4 View
NCT00045994 Synvista Therapeutics, Inc COMPLETED The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling PHASE2 View
NCT00045968 Positive Gene Therapy Northwest Biotherapeutics UNKNOWN Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer PHASE3 View
NCT00045903 New York State Psychiatric Institute COMPLETED Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder NA View
NCT00045760 Eli Lilly and Company COMPLETED The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis PHASE4 View
NCT00045734 National Cancer Institute (NCI) COMPLETED Imatinib Mesylate in Treating Patients With Recurrent Meningioma PHASE2 View
NCT00045695 NCIC Clinical Trials Group COMPLETED Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia PHASE2 View
NCT00045669 University Health Network, Toronto COMPLETED Imatinib Mesylate in Treating Patients With Salivary Gland Cancer PHASE2 View
NCT00045604 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer PHASE1 View
NCT00045461 Ludwig-Maximilians - University of Munich UNKNOWN Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer PHASE2 View
NCT00045435 Fred Hutchinson Cancer Center COMPLETED Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission PHASE2 View
NCT00045357 Fred Hutchinson Cancer Center COMPLETED Biological Therapy in Treating Patients With Metastatic Melanoma PHASE1 View
NCT00045318 Jonsson Comprehensive Cancer Center COMPLETED Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction PHASE1 View
NCT00045305 Eastern Cooperative Oncology Group COMPLETED Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes PHASE2 View
NCT00045292 Fred Hutchinson Cancer Center COMPLETED Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation PHASE3 View
NCT00045266 Regeneron Pharmaceuticals COMPLETED VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma PHASE1 View
NCT00045032 Hoffmann-La Roche COMPLETED Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer PHASE3 View
NCT00045006 Memorial Sloan Kettering Cancer Center COMPLETED Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer PHASE1 View
NCT00044993 Possible Gene Therapy Introgen Therapeutics COMPLETED Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer PHASE2 View
NCT00044967 Alliance for Clinical Trials in Oncology COMPLETED Genetic Study of Young Patients With Colorectal Cancer View
NCT00044902 Amgen COMPLETED Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) PHASE2 View
NCT00044759 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma PHASE3 View
NCT00044733 Positive Gene Therapy Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant PHASE2 View
NCT00044720 Wyeth is now a wholly owned subsidiary of Pfizer COMPLETED Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients PHASE4 View
NCT00044694 AstraZeneca COMPLETED Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus PHASE2 View
NCT00044668 AstraZeneca COMPLETED Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination PHASE3 View
NCT00044603 National Institute of Environmental Health Sciences (NIEHS) COMPLETED Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS. View
NCT00044551 Bayer COMPLETED Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma PHASE2 View
NCT00044512 Bayer COMPLETED A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma PHASE2 View